Abstract
PIWI-interacting RNAs (piRNAs) have received a lot of attention for their functions in cancer research. This class of short non-coding RNAs (ncRNA) has roles in genomic stability, chromatin remodeling, messenger RNA (mRNA) integrity, and genome structure. We summarized the mechanisms underlying the biogenesis and regulatory molecular functions of piRNAs. Among all piRNAs studied in cancer, this review offers a comprehensive analysis of the emerging roles of piR-823 in various types of cancer, including colorectal, gastric, liver, breast, and renal cancers, as well as multiple myeloma. piR-823 has emerged as a crucial modulator of various cancer hallmarks through regulating multiple pathways. In the current review, we analyzed several databases and conducted an extensive literature search to explore the influence of piR-823 in carcinogenesis in addition to describing the potential application of piR-823 as prognostic and diagnostic markers as well as the therapeutic potential toward ncRNA precision.
| Original language | English |
|---|---|
| Pages (from-to) | 47-68 |
| Number of pages | 22 |
| Journal | Naunyn-Schmiedeberg's Archives of Pharmacology |
| Volume | 398 |
| Issue number | 1 |
| DOIs | |
| Publication status | Accepted/In press - 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer hallmarks
- In silico
- ncRNA
- piR-823
- piRNA
- Precision
ASJC Scopus subject areas
- Pharmacology
Fingerprint
Dive into the research topics of 'piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: a step-toward ncRNA-precision'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS